Aurobindo Pharma has launched COVID-19 treatment drug Molnupiravir under the brand name ''Molnaflu'' in India. Molnupiravir is for treatment of adult patients hospitalized with COVID-19, under certain conditions.
Molnupiravir was earlier approved under Emergency Use Authorisation from the Central Drugs Standard Control Organisation.
Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.
